Donna Grogan

Donna Roy Grogan currently works at C4 Therapeutics, Inc., as Independent Director from 2022 and Clementia Pharmaceuticals USA, Inc., as President from 2014.
Dr. Grogan also formerly worked at Momenta Pharmaceuticals, Inc., as Independent Director from 2019 to 2020, Astra Pharmaceuticals, Inc., as Medical Director, Sumitomo Pharma America, Inc., as Senior Vice President-Clinical Research from 2000 to 2007, DecImmune Therapeutics, Inc., as Chief Medical Officer, Apofore Corp., as Chief Medical Officer, Anexon, Inc., as Chief Medical Officer, Clementia Pharmaceuticals, Inc., as Chief Medical Officer from 2013 to 2019, and FoldRx Pharmaceuticals LLC, as Chief Medical Officer from 2007 to 2010.
Dr. Grogan received her undergraduate degree from College of the Holy Cross (Massachusetts) and doctorate degree from the University of Illinois College of Medicine.